Hemab Aps
Clinical trials sponsored by Hemab Aps, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New study tracks bleeding in von willebrand disease to pave way for better treatments Results expected Dec 2026 (estimated)
- Can a single injection of HMB-003 be safe for humans? a first test begins Results expected Apr 2027 (estimated)
- New hope for bleeding disorder: first human trial of HMB-002 begins Results expected Jul 2027 (estimated)
- New antibody aims to stop bleeding episodes in rare clotting disorder Results expected Aug 2027 (estimated)